Bharat Book Bureau Provides the Trending Market Research Report on “Global Biopsy Devices Market, Forecast to 2024” under Life Sciences category. The report provides information on industry overview, market size, latest developments, industry trends, Key Companies, global presence, and their future prospects.
Global Biopsy devices market is expected to reach US$ 3 Billion by 2024. This report discusses the Biopsy devices, as we all are aware that biopsy is a system or tool which is used for care and analysis of cancer prevalence as well as growing demand for minimal invasive procedures.
The factors that drive the Biopsy market globally are the growing cancer prevalence say for instance Prostate, Breast, and Lungs as well as an inclination towards minimally invasive surgeries and the rising geriatric populace. Some of the growth factors of this market were growing awarness among public as well as discoveries in newer technologies.
“Biopsy Devices Market, Global Forecast, by Products (Biopsy Needles, Guidance Systems, Biopsy Guns Reagents and kits and others), Regions (North America, Europe, Asia-Pacific & Rest of the World), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy and Others) Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, Hologic, Inc.)” captures a detailed analysis of global Biopsy Devices market and volume and provides an all-encompassing analysis of the key growth drivers and preventive factors, key players and their projections for the future.
Request a free sample copy of Biopsy Devices Market Report @ https://www.bharatbook.com/request-sample/651350
By Segmentation - Global Biopsy Devices Market
This report lets you know about the segmentation of global biopsy market say for instance Biopsy Needles is an attractive market of global biopsy market. Nowadays, increasing use of Biopsy Guns in surgery is making a great impact on this market, and it will grow at a noteworthy rate during the projected time frame.
Besides, this report also discusses about the market of Guidance system, say for instance (Clinically-guided, Stereotactic-guided, Ultrasound-guided) and Reagents & kits system. The above mentioned markets of devices, make a great impact on this market due to inclination on minimally invasive surgeries as well as rising prevalence of cancer’s like Prostate, Breast and Lungs.
On the basis of application, Lung Biopsy and Breast Biopsy markets together dominate the market share of Biopsy Devices Market globally. Although, Prostate Biopsy market share is growing annually at a significant rate.
On the basis of regions, North America and Europe together captures the market share of the Biopsy Devices Market globally. At the same time, the Asia-Pacific region Biopsy Devices Market is projected to grow more rapidly over the projected time period.
The key players in this industry include C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, Boston Scientific Corporation, Medtronic plc, and Hologic, Inc. The company focuses on the development of new products, partnerships and acquisitions to maintain their positions in the market.
All the 8 companies studied in the report have been studied from 4 points
- Business Strategy – This section provides company marketing strategy
- Merger & Acquisition – This section captures 5 years M&A data
- Financial Insight – This section provides sales of (2010 to 2017) & forecast (2018 to 2024)
This 154 page report with 59 Figures and 2 Tables provides a complete analysis of the Global Biopsy Devices Market, Forecast key Growth Drivers and Challenges.
Biopsy Segments Covered in the Report:
- Biopsy Needles
- Guidance Systems
- Biopsy Guns
- Reagents and kits
Regional Market Covered in the Report:
- North America
- Rest of the World
Key Companies Covered in the Report:
- C. R. Bard, Inc.
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Olympus Corporation
- Boston Scientific Corporation
- Medtronic plc
- Hologic, Inc.
To browse full research report with TOC, click the link below :
- 12Avg Daily Vews
- 1 Day
- 1 Week
- 1 Month
- 2 Months
- 6 Months
- 1 Year